Clinical Trial Update: Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month [Phase 3]

View source ↗

Summary

Phase 3 trial update for a novel influenza A/H1N1 split-virion vaccine in healthy children aged 6 to 35 months; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Swine-origin Influenza Infection

Drugs mentioned

• Novel Influenza A/H1N1 Split-Virion Vaccine

Snippet

Sponsor: Centers for Disease Control and Prevention, China | Conditions: Influenza, Swine-origin A/H1N1 Influenza | Phase 3 | Status: UNKNOWN